OKYO Pharma Stock (NASDAQ:OKYO)
Previous Close
$2.75
52W Range
$0.81 - $3.11
50D Avg
$2.35
200D Avg
$1.47
Market Cap
$102.67M
Avg Vol (3M)
$187.80K
Beta
-4.20
Div Yield
-
OKYO Company Profile
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.